Read + Share
da Costa AABA, Souza RP, Pandolfi NC, de Souza Castro F, et al. Should we consider progression-free survival benefits enough for drug approvals
in locally advanced cervical cancer? Gynecol Oncol 2024;189:109-110.
PMID: 39084160
|
 |
|
da Costa AABA, Souza RP, Pandolfi NC, de Souza Castro F, et al. Should we consider progression-free survival benefits enough for drug approvals
in locally advanced cervical cancer? Gynecol Oncol 2024;189:109-110.
PMID: 39084160
|
|
|
|